In periodontal diseases, NF-κB differentiates and progresses osteoclastic activity, whereas PPAR-γ is an anti-inflammatory nuclear hormone receptor that modulates NF-κB signaling. This evidence concerns the gene NFKB1 and periodontal disorder.